Yu Xia - Dec 31, 2023 Form 5 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Yu Xia
Stock symbol
SMMT
Transactions as of
Dec 31, 2023
Transactions value $
$47,699,707
Form type
5
Date filed
2/14/2024, 04:35 PM
Previous filing
Jan 26, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Purchase $22.6M +21.5M $1.05 21.5M Mar 7, 2023 Akeso, Inc. F1, F3
transaction SMMT Common Stock Purchase $25.1M +10M $2.51 10M Jan 17, 2023 Akeso, Inc. F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 21,523,530 shares of the Issuer's Common Stock were acquired on March 7, 2023 through a rights offering.
F2 10,000,000 shares of the Issuer's Common Stock were issued on January 17, 2023 in connection with the Collaboration and License Agreement with Akeso, Inc.("Akeso") pursuant to which the Issuer issued Akeso such shares.
F3 Akeso is the direct beneficial owner of the shares of the Issuer's Common Stock. Dr. Xia is a stockholder and exercises the right to vote approximately 28.9% of Akeso's ordinary shares, and serves as chairwoman, president and chief executive officer of Akeso. Dr. Xia disclaims beneficial ownership of the shares of Issuer's Common Stock beneficially owned by Akeso, except to the extent of her pecuniary interest.